| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yann Chye, Valentina Lorenzetti, Chao Suo, Albert Batalla, Janna Cousijn, Anna E Goudriaan, Mark Jenkinson, Rocio Martin-Santos, Sarah Whittle, Murat Yücel, Nadia Solowi. Alteration to hippocampal volume and shape confined to cannabis dependence: a multi-site study. Addiction biology. vol 24. issue 4. 2020-08-10. PMID:30022573. |
cannabis users did not differ from controls in hippocampal volume or shape. |
2020-08-10 |
2023-08-13 |
Not clear |
| Roger Hudson, Justine Renard, Christopher Norris, Walter J Rushlow, Steven R Laviolett. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 39. issue 44. 2020-06-29. PMID:31570536. |
cannabidiol counteracts the psychotropic side-effects of Δ-9-tetrahydrocannabinol in the ventral hippocampus through bidirectional control of erk1-2 phosphorylation. |
2020-06-29 |
2023-08-13 |
Not clear |
| Carlos Jimenez Naranjo, Ashleigh L Osborne, Katrina Weston-Gree. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 94. 2020-03-30. PMID:31108177. |
effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly i:c rat model of schizophrenia. |
2020-03-30 |
2023-08-13 |
rat |
| Rocio Saravia, Marc Ten-Blanco, María T Grande, Rafael Maldonado, Fernando Berrender. Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain, behavior, and immunity. vol 75. 2020-01-23. PMID:30391635. |
treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of il1β and ifnγ in the hippocampus and the prefrontal cortex, respectively, and normalized ki67 levels. |
2020-01-23 |
2023-08-13 |
mouse |
| Ariandra G Sartim, Amanda J Sales, Francisco S Guimarães, Sâmia Rl Joc. Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test. Journal of psychopharmacology (Oxford, England). vol 32. issue 8. 2019-11-12. PMID:29968502. |
hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test. |
2019-11-12 |
2023-08-13 |
Not clear |
| Archie A Khan, Tawfeeq Shekh-Ahmad, Ayatakin Khalil, Matthew C Walker, Afia B Al. Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model. British journal of pharmacology. vol 175. issue 11. 2019-08-06. PMID:29574880. |
cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model. |
2019-08-06 |
2023-08-13 |
Not clear |
| Valentina Lorenzetti, Yann Chye, Pedro Silva, Nadia Solowij, Carl A Robert. Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies. European archives of psychiatry and clinical neuroscience. vol 269. issue 1. 2019-06-05. PMID:30706169. |
regular cannabis users had significantly smaller volumes of the hippocampus (smd = 0.14, 95% cis [0.02, 0.27]; z = 2.29, p = 0.02, i |
2019-06-05 |
2023-08-13 |
human |
| Blathnaid Hughes, Caroline E Herro. Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease. Neurochemical research. vol 44. issue 3. 2019-05-07. PMID:29574668. |
cannabidiol reverses deficits in hippocampal ltp in a model of alzheimer's disease. |
2019-05-07 |
2023-08-13 |
Not clear |
| Amanda Nunes Santiago, Marco Aurélio Mori, Francisco Silveira Guimarães, Humberto Milani, Rúbia Maria Weffort de Oliveir. Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats. Neurotoxicity research. vol 35. issue 2. 2019-03-11. PMID:30430393. |
cannabidiol improved memory performance and reduced hippocampal levels of inflammation markers (inducible nitric oxide synthase, ionized calcium-binding adapter molecule 1, glial fibrillary acidic protein, and arginase 1). |
2019-03-11 |
2023-08-13 |
rat |
| Amanda Nunes Santiago, Marco Aurélio Mori, Francisco Silveira Guimarães, Humberto Milani, Rúbia Maria Weffort de Oliveir. Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats. Neurotoxicity research. vol 35. issue 2. 2019-03-11. PMID:30430393. |
cannabidiol attenuated the decrease in hippocampal levels of brain-derived neurotrophic factor induced by cch in diabetic animals, but it did not affect the levels of neuroplasticity markers (growth-associated protein-43 and synaptophysin) in middle-aged diabetic rats. |
2019-03-11 |
2023-08-13 |
rat |
| Miguel Ángel Luján, Adriana Castro-Zavala, Laia Alegre-Zurano, Olga Valverd. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus. Neuropharmacology. vol 143. 2019-02-25. PMID:30273593. |
repeated cannabidiol treatment reduces cocaine intake and modulates neural proliferation and cb1r expression in the mouse hippocampus. |
2019-02-25 |
2023-08-13 |
mouse |
| Alex Straiker, Michaela Dvorakova, Anaelle Zimmowitch, Ken Macki. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Molecular pharmacology. vol 94. issue 1. 2019-02-22. PMID:29669714. |
cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons. |
2019-02-22 |
2023-08-13 |
Not clear |
| Cristina A J Stern, Thiago R da Silva, Ana M Raymundi, Camila P de Souza, Vinicius A Hiroaki-Sato, Luiza Kato, Francisco S Guimarães, Roberto Andreatini, Reinaldo N Takahashi, Leandro J Bertogli. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB Neuropharmacology. vol 125. 2018-06-12. PMID:28754373. |
cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus cb pharmacological interventions able to modulate a fear memory while it is consolidated could have therapeutic value in tempering those maladaptively overconsolidated. |
2018-06-12 |
2023-08-13 |
human |
| Carl R Lupica, Yuhan Hu, Orrin Devinsky, Alexander F Hoffma. Cannabinoids as hippocampal network administrators. Neuropharmacology. vol 124. 2018-05-09. PMID:28392266. |
we also examine potential roles for the hippocampal formation in mediating dysfunctional behavior, and assert that these phenomena reflect disordered physiological activity within the hippocampus and its interactions with other brain regions after exposure to synthetic cannabinoids, and the phytocannabinoids found in marijuana, such as Δ |
2018-05-09 |
2023-08-13 |
Not clear |
| L Koenders, V Lorenzetti, L de Haan, C Suo, Wam Vingerhoets, W van den Brink, R W Wiers, C J Meijer, Mwj Machielsen, A E Goudriaan, D J Veltman, M Yücel, J Cousij. Longitudinal study of hippocampal volumes in heavy cannabis users. Journal of psychopharmacology (Oxford, England). vol 31. issue 8. 2018-04-20. PMID:28741422. |
longitudinal study of hippocampal volumes in heavy cannabis users. |
2018-04-20 |
2023-08-13 |
Not clear |
| L Koenders, V Lorenzetti, L de Haan, C Suo, Wam Vingerhoets, W van den Brink, R W Wiers, C J Meijer, Mwj Machielsen, A E Goudriaan, D J Veltman, M Yücel, J Cousij. Longitudinal study of hippocampal volumes in heavy cannabis users. Journal of psychopharmacology (Oxford, England). vol 31. issue 8. 2018-04-20. PMID:28741422. |
cannabis exposure, particularly heavy cannabis use, has been associated with neuroanatomical alterations in regions rich with cannabinoid receptors such as the hippocampus in some but not in other (mainly cross-sectional) studies. |
2018-04-20 |
2023-08-13 |
Not clear |
| L Koenders, V Lorenzetti, L de Haan, C Suo, Wam Vingerhoets, W van den Brink, R W Wiers, C J Meijer, Mwj Machielsen, A E Goudriaan, D J Veltman, M Yücel, J Cousij. Longitudinal study of hippocampal volumes in heavy cannabis users. Journal of psychopharmacology (Oxford, England). vol 31. issue 8. 2018-04-20. PMID:28741422. |
however, it remains unclear whether continued heavy cannabis use alters hippocampal volume, and whether an earlier age of onset and/or a higher dosage exacerbate these changes. |
2018-04-20 |
2023-08-13 |
Not clear |
| Daniel G Amen, Borhan Darmal, Cyrus A Raji, Weining Bao, Lantie Jorandby, Somayeh Meysami, Cauligi S Raghavendr. Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia. Journal of Alzheimer's disease : JAD. vol 56. issue 1. 2018-02-21. PMID:27886010. |
discriminative properties of hippocampal hypoperfusion in marijuana users compared to healthy controls: implications for marijuana administration in alzheimer's dementia. |
2018-02-21 |
2023-08-13 |
Not clear |
| Yann Chye, Chao Suo, Murat Yücel, Lauren den Ouden, Nadia Solowij, Valentina Lorenzett. Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology. vol 234. issue 14. 2018-02-07. PMID:28424833. |
cannabis use is associated with neuroanatomical alterations in the hippocampus. |
2018-02-07 |
2023-08-13 |
Not clear |
| Yann Chye, Chao Suo, Murat Yücel, Lauren den Ouden, Nadia Solowij, Valentina Lorenzett. Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology. vol 234. issue 14. 2018-02-07. PMID:28424833. |
while the hippocampus is composed of multiple subregions, their differential vulnerability to cannabis dependence remains unknown. |
2018-02-07 |
2023-08-13 |
Not clear |